The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia

Recent Advances in MS Therapy

1,2,3Seraj Makkawi, 4Nedaa Alsulaimani, 1Fahad A Alharbi, 4Reem Brashi, 4Renad Melebary, 4Shuaa Aljabri, 4Khalid Altowairqi, 4Albaraa Ashoor, 4Amal Alkhotani 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences & King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; 2King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; 3Department of Medicine, Ministry of the…

Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut

Pediatric MS

1Georges Saab, 2Nabil El Ayoubi, 2Samia Khoury 1University of Toronto-BARLO Multiple Sclerosis Center, Toronto, Canada; 2Nehme and Therese Tohme Multiple Sclerosis Center at the American University of Beirut, Beirut, Lebanon Background: Multiple Sclerosis (MS) is an autoimmune demyelinating disease that affects the central nervous system of individuals with peak incidence between the ages of 20-40.…

Lennox-Gastaut Syndrome and MS: Is it a Coincidence?

Pediatric MS

1Lilia Megherbi, 1Hakim Si Ahmed, 1Smail Daoudi 1Tizi Ouzou University Hospital, Tizi Ouzou, Algeria Introduction: Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS). Several associations with MS have been described, including epilepsy but not a particular epileptic syndrome, such as Lennox-Gastaut syndrome. We report an exceptional presentation of MS…

NMOSD: How Long to Treat

Neuromyelitis Optica

1Rajarshi Chakraborty 1King George Medical University, Lucknow, India Introduction: Neuromyelitis optica spectrum disorder is a debilitatively relapsing autoimmune neurological disorder affecting young adults. With the advent of steroids, plasma exchange and immunomodulator therapy, the course of the disorder can be controlled upto a comprehensive extent. But the real question is : how long? Material(s) and…

The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran.

Neuromyelitis Optica

1Roshanak Mehdipour Dastjerdi, 1Fereshteh Ashtari 1Isfahan University of Medical Sciences, Isfahan, Iran Background: Coronavirus 2019 (called COVID19) is a new coronavirus which has created a pandemic since early 2020. NMOSD patients are more affected by psychological effects of COVID19 pandemic such as anxiety and fear because they may be worried about being infected by COVID19…

A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica

1Roshanak Mehdipour, 2Vahid Shaygannejad 1Isfahan Neuroscience Research Center, Isfahan University Of Medical Sciences, Isfahan, Iran; 2Isfahan Neuroscience Research Center, Alzahra Research Institute, Isfahan, University of Medical Science, Isfahan, Iran Background: NMOSD is an immune-mediated disorder which is characterized by relapsing episodes of optic neuritis and myelitis. Brain stem related symptoms such as Intractable vomiting are…

Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population

Neuromyelitis Optica

1Kediha Mohamed Islam, 1Moualek Dalila, 1Bouakaz Imene Fatma, 1Ali Pacha Lamia 1Neurology Department, Mustapha Bacha University Hospital, Algiers, Algeria Introduction: Inflammatory optic neuropathies (ION) represent frequent neuro-ophthalmological emergencies, sources of severe functional handicap. They often pose an etiological problem. Objective(s): To study the clinical, radiological, etiological and evolutionary particularities of ION in Algerian patients. Material(s)…

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography

Neuromyelitis Optica

1Rehab Magdy 1Cairo University, Cairo, Egypt Background: Cognitive impairment in neuromyelitis optica spectrum disorder (NMOSD) is not uncommon occurring independent from attacks and lesions. It presents in about 30-70% of NMOSD patients. Psychiatric symptoms may be initial manifestation of NMOSD, and depression is not uncommon. NMOSD patients showed global brain atrophy however it is not…

Association of Multiple Sclerosis and COVID-19 Infection: A Case Report

MS Pathology

1Ismail Ibrahim Ismail, 1,2Jasem Al-Hashel, 3Raed Alroughani, 1,4Samar Farouk Ahmed 1Ibn Sina Hospital, Kuwait city, Kuwait; 2Health Sciences Centre, Kuwait University, Jabriya, Kuwait; 3Amiri Hospital, Sharq, Kuwait; 4Minia University, Minia, Egypt Introduction: Since the declaration of COVID-19 pandemic, several cases of demyelination of both peripheral and central nervous systems have been reported. The association of…

Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking?

MS Pathology

1Razieh Mofateh, 2Reza Salehi, 3Hossein Negahban, 1Mohammad Mehravar, 4Shirin Tajali, 1Saeideh Monjezi 1Musculoskeletal Rehabilitation Research Center, Department of Physiotherapy, School of Rehabilitation sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Rehabilitation Research Center, and School of Rehabilitation Sciences, Department of Rehabilitation Management, Iran University of Medical Sciences, Tehran, Iran; 3Mashhad University of Medical Sciences,…